|
|
Susan Graver
Group Director - Global Pharmacovigilance and Epidemiology
Bristol-Myers Squibb
Prof Philippe Van der Auwera
Global Head of Safety Risk Management and EU-QPPV
F-Hoffman La Roche
Dr Beverley Forsythe
Principal Safety Physician R&D, Clinical Development, Patient Safety
AstraZeneca
Dr Larry Johnson
Executive Director, Global Safety Head of Therapeutic Area Safety
Amgen
|
Conference:
Pre-conference workshop
14 Sept 9am - 5pm
Day 1
15 Sept 8am - 5:30pm
Day 2
16 Sept 8am - 5:30pm
Post-conference workshop
17 Sept 9am - 5pm
|
|
|
The 3rd annual World Drug Safety Congress Europe is your best chance to do drug safety business globally.
World Drug Safety Congress Europe is where people come to look for advice, guidance and support to the key challenges they face. As a CRO or technology provider with solutions to offer, this conference represents an exceptional opportunity to develop new business relationships.
|
|
This is what our previous sponsors had to say..
"Good presentations, good mix of attendees (pharma, agencies/academics, vendors), professionally organized."
VP Safety and Risk Management, PRA International
"Best organized event I have participated in during the last 12 months."
Director Observational Studies, Covance
"Targeted audience, intimate setting, multiple networking opportunities, good booth traffic."
VP eLearning + Informatics, BioSoteria
"Good size, easy to network. We will participate at a higher level next year."
Director, Parexel
» Find out about sponsorship
|
|
|
Who should sponsor?
World-class solutions providers who need to position their products and services in front of decision makers from major pharmaceutical manufacturers and biotechnology companies:
- Contract Research Organisation
- Equipment Providers
- Biotechnology Companies
- Pharmaceutical Manufacturers
- Consultants
- Venture Capitalists
|
|
|
|
|
|
|
|
|
|
|
